BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19638909)

  • 1. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.
    Kuramoto M; Shimada S; Ikeshima S; Matsuo A; Yagi Y; Matsuda M; Yonemura Y; Baba H
    Ann Surg; 2009 Aug; 250(2):242-6. PubMed ID: 19638909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial.
    Yang HK; Ji J; Han SU; Terashima M; Li G; Kim HH; Law S; Shabbir A; Song KY; Hyung WJ; Kosai NR; Kono K; Misawa K; Yabusaki H; Kinoshita T; Lau PC; Kim YW; Rao JR; Ng E; Yamada T; Yoshida K; Park DJ; Tai BC; So JBY;
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):120-127. PubMed ID: 33253659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.
    Masuda T; Kuramoto M; Shimada S; Ikeshima S; Yamamoto K; Nakamura K; Yoshimatsu S; Urata M; Baba H
    Int J Clin Oncol; 2016 Apr; 21(2):289-294. PubMed ID: 26296529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Trial.
    Guo J; Xu A; Sun X; Zhao X; Xia Y; Rao H; Zhang Y; Zhang R; Chen L; Zhang T; Li G; Xu H; Xu D
    JAMA Surg; 2019 Jul; 154(7):610-616. PubMed ID: 30916742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
    Misawa K; Mochizuki Y; Sakai M; Teramoto H; Morimoto D; Nakayama H; Tanaka N; Matsui T; Ito Y; Ito S; Tanaka K; Uemura K; Morita S; Kodera Y;
    Br J Surg; 2019 Nov; 106(12):1602-1610. PubMed ID: 31573086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells.
    Shimada S; Tanaka E; Marutsuka T; Honmyo U; Tokunaga H; Yagi Y; Aoki N; Ogawa M
    Gastric Cancer; 2002; 5(3):168-72. PubMed ID: 12378344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended intraoperative peritoneal lavage as prophylactic peritoneal recurrence for locally advanced gastric cancer: a prospective randomized trial.
    Rodríguez-Santiago J; Luna A; Garsot E; Aldeano A; Balagué C; Rada A
    Clin Transl Oncol; 2021 Sep; 23(9):1857-1865. PubMed ID: 33792839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
    Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
    Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Importance of Extensive Intraoperative Peritoneal Lavage as a Promising Method in Patients with Gastric Cancer Showing Positive Peritoneal Cytology Without Overt Peritoneal Metastasis and Other Therapeutic Approaches.
    Ilhan E; Alemdar A; Ureyen O; Bas K
    J Invest Surg; 2017 Oct; 30(5):318-324. PubMed ID: 27806214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adopting extensive intra-operative peritoneal lavage (EIPL) as the standard prophylactic strategy for peritoneal recurrence.
    Shimada S; Kuramoto M; Marutsuka T; Yagi Y; Baba H
    Rev Recent Clin Trials; 2011 Sep; 6(3):266-70. PubMed ID: 21682671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and outcome of extensive intraoperative peritoneal lavage plus surgery
    Song ED; Xia HB; Zhang LX; Ma J; Luo PQ; Yang LZ; Xiang BH; Zhou BC; Chen L; Sheng H; Fang Y; Han WX; Wei ZJ; Xu AM
    World J Gastrointest Surg; 2023 Mar; 15(3):430-439. PubMed ID: 37032799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PHASE II TRIAL EXPLORING THE EXTENSIVE INTRA-OPERATIVE PERITONEAL LAVAGE (EIPL) AS A PROPHYLACTIC STRATEGY FOR PERITONEAL RECURRENCE IN LOCALLY ADVANCED GASTRIC CANCER: reporting postoperative morbidity and mortality after early closure.
    Batista TP; Martins MR; Martins-Filho ED; Santos RL
    Arq Gastroenterol; 2015; 52(2):161-4. PubMed ID: 26039838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis.
    Marutsuka T; Shimada S; Shiomori K; Hayashi N; Yagi Y; Yamane T; Ogawa M
    Clin Cancer Res; 2003 Feb; 9(2):678-85. PubMed ID: 12576435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.
    Coccolini F; Catena F; Glehen O; Yonemura Y; Sugarbaker PH; Piso P; Ceresoli M; Montori G; Ansaloni L
    Eur J Surg Oncol; 2016 Sep; 42(9):1261-7. PubMed ID: 27134147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive intraperitoneal lavage to eliminate intraperitoneal tumor cells in gastrectomy with D2 lymphadenectomy for gastric cancer.
    Ronellenfitsch U; Ernst K; Mertens C; Trunk MJ; Ströbel P; Marx A; Kienle P; Post S; Nowak K
    Tumori; 2018 Oct; 104(5):361-368. PubMed ID: 30185117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year outcomes of the randomized phase III SEIPLUS trial of extensive intraoperative peritoneal lavage for locally advanced gastric cancer.
    Guo J; Xu A; Sun X; Zhao X; Xia Y; Rao H; Zhang Y; Zhang R; Chen L; Zhang T; Li G; Xu H; Xu D
    Nat Commun; 2021 Nov; 12(1):6598. PubMed ID: 34782599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma.
    Fujimoto S; Takahashi M; Mutou T; Kobayashi K; Toyosawa T
    Cancer; 1999 Feb; 85(3):529-34. PubMed ID: 10091726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 study.
    Misawa K; Mochizuki Y; Ohashi N; Matsui T; Nakayama H; Tsuboi K; Sakai M; Ito S; Morita S; Kodera Y
    Jpn J Clin Oncol; 2014 Jan; 44(1):101-3. PubMed ID: 24287077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.
    Fujimoto T; Zhang B; Minami S; Wang X; Takahashi Y; Mai M
    Oncology; 2002; 62(3):201-8. PubMed ID: 12065866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.